Cerrati Eric W, O Teresa M, Chung Hoyun, Waner Milton
Department of Otolaryngology, New York University, New York, New York, USA
Vascular Birthmark Institute of New York, Lenox Hill and Manhattan Eye, Ear, and Throat Hospitals, New York, New York, USA.
Otolaryngol Head Neck Surg. 2015 Feb;152(2):239-43. doi: 10.1177/0194599814559192. Epub 2014 Dec 1.
Infantile hemangiomas are well known for their rapid growth during the first 6 to 9 months of life, followed by a spontaneous but slow involution. The standard of care is to treat these lesions at an early age with propranolol to expedite the involution process; however, surgery still remains an active component in the management. Medical treatment with propranolol or natural involution will often result in residual telangiectasias. We evaluated the efficacy of using a diode laser as a treatment for telangiectasias following cervicofacial infantile hemangioma involution.
Case series with chart review.
Tertiary care hospital and practice specializing in the care of vascular anomalies.
Twenty patients, aged 4 months to 11 years (average 2.69 years), underwent treatment with a 532-nm diode laser to treat the residual telangiectasias following hemangioma involution. All procedures were performed in the operating room. To assess the efficacy, we independently evaluated pre- and posttreatment digital photographs and ranked them on a 0- to 4-point scale (0 = no change and 4 = complete response). Adverse reactions were also recorded.
The telangiectasias showed considerable improvement following treatment. In more than half of the patients treated, the affected area demonstrated a complete response. No adverse reactions were noted.
A 532-nm diode laser effectively treats the remaining telangiectasias following hemangioma involution. Whether used independently or in conjunction with other treatment modalities, the diode laser should be part of the surgical armamentarium when treating infantile hemangiomas.
婴儿血管瘤以在出生后6至9个月内快速生长而闻名，随后是自发但缓慢的消退。护理标准是在早期用普萘洛尔治疗这些病变以加速消退过程；然而，手术仍然是治疗中的一个重要组成部分。用普萘洛尔进行药物治疗或自然消退通常会导致残留的毛细血管扩张。我们评估了使用二极管激光治疗面颈部婴儿血管瘤消退后的毛细血管扩张的疗效。
病例系列并进行病历回顾。
一家专门治疗血管异常的三级护理医院及诊所。
20例年龄在4个月至11岁（平均2.69岁）的患者，接受了532纳米二极管激光治疗，以治疗血管瘤消退后的残留毛细血管扩张。所有手术均在手术室进行。为了评估疗效，我们独立评估治疗前和治疗后的数码照片，并按0至4分的量表进行评分（0 = 无变化，4 = 完全缓解）。还记录了不良反应。
治疗后毛细血管扩张有显著改善。在接受治疗的患者中，超过一半的患者病变区域显示完全缓解。未观察到不良反应。
532纳米二极管激光能有效治疗血管瘤消退后残留的毛细血管扩张。无论是单独使用还是与其他治疗方式联合使用，二极管激光都应成为治疗婴儿血管瘤时手术器械的一部分。
